miRNA-218 Inhibits Osteosarcoma Cell Migration and Invasion by Down-regulating of TIAM1, MMP2 and MMP9

  • Jin, Jie (Department of Orthopedics, Zhongnan Hospital of Wuhan University) ;
  • Cai, Lin (Department of Orthopedics, Zhongnan Hospital of Wuhan University) ;
  • Liu, Zhi-Ming (Department of Orthopedics, Tongren Hospital of Wuhan) ;
  • Zhou, Xue-Song (Department of Orthopedics, Tongren Hospital of Wuhan)
  • Published : 2013.06.30


Deregulated miRNAs participate in osteosarcoma genesis. In this study, the expression of miRNA-218 in human osteosarcomas, adjacent normal tissues and Saos-2 human osteosarcoma cells was first assessed. Then the precise role of miRNA-218 in osteosarcoma cells was investigated. Upon transfection with a miR-218 expression vector, the proliferation of Saos-2 human osteosarcoma cells determined using the ATPlite assay was significantly suppressed, whilw migration of Saos-2 cells detected by wound healing and invasion determined using transwells were dramatically inhibited. Potential target genes of miR-218 were predicted and T-cell lymphoma invasion and metastasis 1 (TIAM1) and matrix metalloproteinase 2 (MMP2) and 9 (MMP9) were identified. This was confirmed by western blotting, which showed that miR-218 expression inhibited TIAM1, MMP2 and MMP9 protein expression. Collectively, these data suggest that miR-218 acts as a tumor suppressor in osteosarcomas by down-regulating TIAM1, MMP2 and MMP9 expression.


  1. Habets GG, Scholtes EH, Zuydgeest D, et al (1994). Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell, 77, 537-49.
  2. He X, Dong Y, Wu CW, et al (2013). MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene. Mol Med, 18, 1491-8.
  3. Alajez NM, Lenarduzzi M, Ito E, et al (2011). MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Res, 71, 2381-91.
  4. Dieckmann KP, Spiekermann M, Balks T, et al (2012). MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours. Br J Cancer, 107, 1754-60.
  5. Hagman Z, Haflidadottir BS, Ceder JA, et al (2013). miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients. Br J Cancer, 108, 1668-76.
  6. Jin Y, Peng D, Shen Y, et al (2013). MicroRNA-376c Inhibits Cell Proliferation and Invasion in Osteosarcoma by Targeting to Transforming Growth Factor-Alpha. DNA Cell Biol, 32, 302-9.
  7. Kawauchi T, Chihama K, Nabeshima Y, et al (2003). The in vivo roles of STEF/Tiam1, Rac1 and JNK in cortical neuronal migration. EMBO J, 22, 4190-201.
  8. Kinoshita T, Hanazawa T, Nohata N, et al (2012). Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma. Oncotarget, 3, 1386-400.
  9. Li J, Liang S, Jin H, et al (2012). Tiam1, negatively regulated by miR-22, miR-183 and miR-31, is involved in migration, invasion and viability of ovarian cancer cells. Oncol Rep, 27, 1835-42.
  10. Liu Y, Yan W, Zhang W, et al (2012). MiR-218 reverses high invasiveness of glioblastoma cells by targeting the oncogenic transcription factor LEF1. Oncol Rep, 28, 1013-21.
  11. Long XH, Mao JH, Peng AF, et al (2013). Tumor suppressive microRNA-424 inhibits osteosarcoma cell migration and invasion via targeting fatty acid synthase. Exp Ther Med, 5, 1048-52.
  12. Mao JH, Zhou RP, Peng AF, et al (2012). microRNA-195 suppresses osteosarcoma cell invasion and migration in vitro by targeting FASN. Oncol Lett, 4, 1125-29.
  13. Nana-Sinkam SP, Croce CM (2013). Clinical applications for microRNAs in cancer. Clin Pharmacol Ther, 93, 98-104.
  14. Ottaviani G, Jaffe N (2009). The epidemiology of osteosarcoma. Cancer Treat Res, 152, 3-13.
  15. Osman A (2012). MicroRNAs in health and disease--basic science and clinical applications. Clin Lab, 58, 393-402.
  16. Qin S, Ai F, Ji WF, et al (2013). miR-19a Promotes Cell Growth and Tumorigenesis through Targeting SOCS1 in GastricCancer. Asian Pac J Cancer Prev, 14, 835-40.
  17. Takahashi M, Cuatrecasas M, Balaguer F, et al (2012). The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer. PLoS One, 7, e46684.
  18. Venkataraman S, Birks DK, Balakrishnan I, et al (2013). MicroRNA 218 acts as a tumor suppressor by targeting multiple cancer phenotype-associated genes in medulloblastoma. J Biol Chem, 288, 1918-28.
  19. Wu X, Zhong D, Gao Q, et al (2013). MicroRNA-34a Inhibits Human Osteosarcoma Proliferation by Downregulating Ether a go-go 1 Expression. Int J Med Sci, 10, 676-82.

Cited by

  1. Halofuginone induces the apoptosis of breast cancer cells and inhibits migration via downregulation of matrix metalloproteinase-9 vol.44, pp.1, 2013,
  2. Review of the Molecular Pathogenesis of Osteosarcoma vol.15, pp.15, 2014,
  3. Radixin Knockdown by RNA Interference Suppresses Human Glioblastoma Cell Growth in Vitro and in Vivo vol.15, pp.22, 2014,
  4. A New Paradigm to Mitigate Osteosarcoma by Regulation of MicroRNAs and Suppression of the NF-κB Signaling Cascade vol.18, pp.4, 2014,
  5. Significance of MTA1 in the molecular characterization of osteosarcoma vol.33, pp.4, 2014,
  6. The downregulation of miR-144 is associated with the growth and invasion of osteosarcoma cells through the regulation of TAGLN expression vol.34, pp.6, 2014,
  7. LEF1 regulates glioblastoma cell proliferation, migration, invasion, and cancer stem-like cell self-renewal vol.35, pp.11, 2014,
  8. MicroRNA-218 inhibits gastrointestinal stromal tumor cell and invasion by targeting KIT vol.35, pp.5, 2014,
  9. miR-34a Inhibits Migration and Invasion of Tongue Squamous Cell Carcinoma via Targeting MMP9 and MMP14 vol.9, pp.9, 2014,
  10. microRNA-218 expression and its association with the clinicopathological characteristics of patients with cervical cancer vol.10, pp.1, 2015,
  11. RETRACTED ARTICLE: Up-regulation of miR-130b expression level and down-regulation of miR-218 serve as potential biomarker in the early detection of human osteosarcoma vol.10, pp.1, 2015,
  12. The Downregulation of MiR-182 Is Associated with the Growth and Invasion of Osteosarcoma Cells through the Regulation of TIAM1 Expression vol.10, pp.5, 2015,
  13. Propofol suppresses proliferation and invasion of glioma cells by upregulating microRNA-218 expression vol.12, pp.4, 2015,
  14. Knockdown of PREX2a inhibits the malignant phenotype of osteosarcoma cells vol.13, pp.2, 2015,
  15. microRNA-218 increase the sensitivity of gastrointestinal stromal tumor to imatinib through PI3K/AKT pathway vol.15, pp.2, 2015,
  16. Functional Roles of N-Linked Glycosylation of Human Matrix Metalloproteinase 9 vol.16, pp.10, 2015,
  17. Prognostic Factors Influencing Clinical Outcomes of Malignant Glioblastoma Multiforme: Clinical, Immunophenotypic, and Fluorescence in Situ Hybridization Findings for 1p19q in 816 Chinese Cases vol.16, pp.3, 2015,
  18. Spinal cord injury induced neuropathic pain: Molecular targets and therapeutic approaches vol.30, pp.3, 2015,
  19. Thermo-chemotherapy Induced miR-218 upregulation inhibits the invasion of gastric cancer via targeting Gli2 and E-cadherin vol.36, pp.8, 2015,
  20. Demethylation of microRNA-142 induced by demethylation agents plays a suppressive role in osteosarcoma cells pp.1792-1082, 2015,
  21. MicroRNA-101 has a suppressive role in osteosarcoma cells through the targeting of c-FOS vol.11, pp.4, 2016,
  22. miRNAs Related to Skeletal Diseases vol.25, pp.17, 2016,
  23. Tumor-suppressing roles of miR-214 and miR-218 in breast cancer vol.35, pp.6, 2016,
  24. MicroRNA-603 functions as an oncogene by suppressing BRCC2 protein translation in osteosarcoma vol.35, pp.6, 2016,
  25. Biological roles of microRNA-140 in tumor growth, migration, and metastasis of osteosarcoma in vivo and in vitro vol.37, pp.1, 2016,
  26. The roles of microRNAs related with progression and metastasis in human cancers vol.37, pp.12, 2016,
  27. RETRACTED ARTICLE: Tissue expression levels of miR-29b and miR-422a in children, adolescents, and young adults’ age groups and their association with prediction of poor prognosis in human osteosarcoma vol.37, pp.3, 2016,
  28. MicroRNA-21 promotes proliferation, invasion and suppresses apoptosis in human osteosarcoma line MG63 through PTEN/Akt pathway vol.37, pp.7, 2016,
  29. Homeodomain-containing gene 10 inhibits cell apoptosis and promotes cell invasion and migration in osteosarcoma cell lines vol.39, pp.5, 2017,
  30. MiR-218 suppresses the metastasis and EMT of HCC cells via targeting SERBP1 vol.49, pp.5, 2017,
  31. Genistein exerts potent antitumour effects alongside anaesthetic, propofol, by suppressing cell proliferation and nuclear factor-κB-mediated signalling and through upregulating microRNA-218 expression in an intracranial rat brain tumour model vol.69, pp.11, 2017,
  32. MicroRNA-26a inhibits osteosarcoma cell proliferation by targeting IGF-1 vol.3, pp.1, 2015,
  33. Prognostic significance of low microRNA-218 expression in patients with different types of cancer vol.95, pp.37, 2016,
  34. MicroRNA-150 functions as an antioncogenic regulator in osteosarcoma vol.14, pp.2, 2017,
  35. MicroRNA-503 suppresses cell proliferation and invasion in osteosarcoma via targeting insulin-like growth factor 1 receptor vol.14, pp.2, 2017,
  36. MicroRNA-335 and its target Rock1 synergistically influence tumor progression and prognosis in osteosarcoma vol.13, pp.5, 2017,
  37. Role of miR-142 in the pathogenesis of osteosarcoma and its potential as therapeutic approach pp.07302312, 2018,
  38. vol.14, pp.12, 2018,
  39. Chalcone Derivatives 4′-Amino-1-Naphthyl-Chalcone (D14) and 4′-Amino-4-Methyl-1-Naphthyl-Chalcone (D15) Suppress Migration and Invasion of Osteosarcoma Cells Mediated by p53 Regulating EMT-Related Genes vol.19, pp.9, 2018,
  40. in human osteosarcoma vol.70, pp.5, 2018,
  41. MicroRNA 483-3p targets Pard3 to potentiate TGF-β1-induced cell migration, invasion, and epithelial–mesenchymal transition in anaplastic thyroid cancer cells pp.1476-5594, 2018,